A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia

Author： Joshi Rohit   Olver Ian   Keefe Dorothy   Marafioti Toni   Smith Keith  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.15, Iss.9, 2007-09, pp. : 1109-1112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of chemotherapy-induced alopecia using an effective scalp cooling system

By Katsimbri P.   Bamias A.   Pavlidis N.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 766-771

Elsevier

Access to resources Recommend Favorite

A Clinical and Biological Guide for Understanding Chemotherapy‐Induced Alopecia and Its Prevention

By  

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 84-96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches

By Hesketh Paul  

Supportive Care in Cancer, Vol. 12, Iss. 8, 2004-08 ,pp. : 543-549

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite

Oral Glutamine in the Prevention of Chemotherapy-induced Gastrointestinal Toxicity

By Muscaritoli M.   Micozzi A.   Conversano L.   Martino P.   Petti M.C.   Cartoni C.   Cascino A.   Rossi-Fanelli F.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 319-320

Elsevier

Access to resources Recommend Favorite